詳細(xì)信息
- ;2,3-二羥基-2-丁烯基-4-(1-羥基-1-甲基乙基)-2-丙基-1-[4-(2-1H-四唑-5-苯基)芐基]咪唑-5-羧酸酯環(huán)-2,3-碳酸酯;OMST;
- olmesartan medoxomil
- ;olmetec;cs-866;MEDOXOMIL;1H-IMIDAZOLE-5-CARBOXYLIC ACID, 4-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-1-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-, (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL ESTER;4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1h-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester;4-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-1-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-IMIDAZOLE-5-CARBOXYLIC ACID (5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL ESTER;2-Butyl-4-(1-hydroxy-1-methylethyl)-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester;Olmesartan Medoximil;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl.5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-ethyl-2-propyl-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate;4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl-1H-Imidazole-5-carboxylic acid, (5-methyl -2-oxo-1,3-dioxol-4-yl) methyl ester;OMST;
- 1.38g/cm3
- 180℃
- 804.2 °C at 760 mmHg
- 440.2 °C
- 熔點(diǎn) 180°C
DECOMPOSITION 180°C - 產(chǎn)地:珠海潤(rùn)都制藥股份有限公司
- CAS NO:144689-63-4
別名/化學(xué)名: 2,3-二羥基-2-丁烯基-4-(1-羥基-1-甲基乙基)-2-丙基-1-[4-(2-1H-四唑-5-苯基)芐基]咪唑-5-羧酸酯環(huán)-2,3-碳酸酯
分子式/結(jié)構(gòu)式:C29H30N6O6
分子量:610.67;
含量(%):≥99.0%;
免責(zé)聲明:以上所展示的信息由企業(yè)自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé),化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。